Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
121.13B | 111.43B | 123.84B | 115.34B | 69.13B | 75.45B | Gross Profit |
15.23B | 13.02B | 13.24B | 15.55B | 9.50B | 8.59B | EBIT |
10.14B | 7.93B | 8.28B | 10.77B | 5.39B | 4.33B | EBITDA |
12.11B | 8.17B | 10.52B | 13.33B | 7.46B | 5.96B | Net Income Common Stockholders |
4.62B | 3.81B | 5.32B | 4.31B | 174.00M | 3.48B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
985.00M | 981.00M | 1.03B | 679.00M | 1.74B | 4.29B | Total Assets |
87.47B | 77.14B | 75.45B | 71.10B | 66.14B | 56.00B | Total Debt |
13.79B | 8.22B | 9.23B | 9.72B | 12.71B | 2.76B | Net Debt |
12.80B | 7.24B | 8.20B | 9.04B | 10.97B | -1.53B | Total Liabilities |
29.84B | 23.53B | 26.31B | 27.21B | 25.73B | 15.64B | Stockholders Equity |
50.98B | 47.44B | 43.38B | 38.52B | 35.22B | 35.45B |
Cash Flow | Free Cash Flow | ||||
0.00 | 970.00M | 836.00M | 4.10B | -9.62B | 9.29B | Operating Cash Flow |
0.00 | 3.70B | 3.24B | 6.28B | -5.40B | 12.07B | Investing Cash Flow |
0.00 | -2.68B | -2.54B | -2.63B | -7.37B | -2.79B | Financing Cash Flow |
0.00 | -1.07B | -553.00M | -4.71B | 10.21B | -6.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | €1.67T | 18.33 | 24.26% | 1.34% | 15.03% | 146.05% | |
70 Outperform | €201.41B | 17.50 | 14.22% | 1.83% | 11.48% | 11.06% | |
69 Neutral | $1.92T | 9.91 | 8.51% | 3.95% | 7.10% | 38.66% | |
65 Neutral | ¥346.29B | 10.39 | 9.85% | 2.30% | 12.20% | ― | |
64 Neutral | $4.38B | 12.03 | 5.25% | 249.91% | 4.11% | -11.02% | |
61 Neutral | ¥31.94B | 6.17 | 2.37% | 7.35% | 19.02% |